The Pulse of Emergency Medicine

Dr. Hector Chapa is joined by esteemed malignant hyperthermia experts Dr. Stacey Watt and Ms. Debbi Conn, RN, HCRM to discuss the importance of a prepared and knowledgeable ambulatory surgery center when diagnosing, treating, and managing a patient presenting with malignant hyperthermia.

Dr. Henry Rosenberg discusses memorable malignant hyperthermia patient cases from his career and the importance of recognizing the triggers and best practices for diagnosis in a clinical setting.

Dr. Christopher Edwards, Assistant Professor Of Anesthesiology at the University of Florida discusses what the key treatment priorities are during an acute malignant hyperthermia episode and how response time may impact the outcome.

Dr. Christopher Edwards, associate professor of anesthesiology from the University of Florida discusses the importance of early recognition of the symptoms characteristic of malignant hyperthermia and how patient survival depends largely on early diagnosis and emergent treatment.

Dr. Christopher Edwards, Assistant Professor Of Anesthesiology at the University of Florida discusses what the key treatment priorities are during an acute malignant hyperthermia episode and how response time may impact the outcome.

Although 6 million patients visit the Emergency Department every year with chest pain symptoms1, less than 4 percent of those visits lead to a diagnosis of acute myocardial infarction2.

To address this gap, Dr. Jennifer Caudle is joined by Dr. Christopher Baugh, Vice Chair of Clinical Affairs at Brigham and Women's Hospital and Associate Professor at Harvard Medical School in Boston Massachusetts, who discusses the adoption of Elecsys Troponin T Gen 5 across the system's Emergency Departments.

References

1. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, https://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf (accessed February 27, 2020).
2. Hsia, R.Y., Z. Hale and J.A. Tabas. (2016). A National Study of the Prevalence of Life-Threatening Diagnoses in Patients with Chest Pain. JAMA Internal Medicine 176(7):1029–1032.

Providing healthcare practitioners with nearly 75 percent of the patient data needed to make a clinical decision, the laboratory can be a valuable partner in improving quality measures and evaluating novel biomarkers throughout a hospital or health system.

Joining Dr Jennifer Caudle is Dr Ibrahim Hashim, Professor and Chief of Clinical Pathology at the University of Texas Southwestern Medical Center and Parkland Memorial Hospital in Dallas Texas, who discusses how the lab played a pivotal role in the adoption of Elecsys Troponin T Gen 5 at Parkland Memorial Hospital.

The benefits of high-sensitive troponin expands beyond the Emergency Department to Cardiology. When used in conjunction with clinical findings, high-sensitive troponins can enable earlier diagnosis of myocardial infarction, more confident dispositions, and improved patient satisfaction than conventional troponins.

Joining Dr Jennifer Caudle is Dr Lori Daniels, Director of the Cardiovascular Intensive Care Unit and the University of California in San Diego, who discusses the adoption of Elecsys Troponin T Gen 5 in her health system.

In this activity, the expert faculty discusses why screening for atrial fibrillation (AF) is important to improve AF burden and outcomes in addition to revealing how app-based wearable technology can assist by providing rhythm information over extended time periods. The faculty explain important aspects of the new Heartline study, which uses the Apple watch and an app to investigate whether early identification, diagnosis, and treatment of atrial fibrillation can lead to better patient outcomes.

Resources found on this page include a Heartline study information and study design guide.

Ever hear that sickle cell disease patients are more likely to become drug abusers? Or that sickle cell pain is just like any other kind of pain? Join mythbuster Dr. Bernard Lopez from Thomas Jefferson University Hospital as he debunks four common misconceptions associated with the pathophysiology and treatment of sickle cell disease in emergency departments.

Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.